POINT BIOPHARMA GLOBAL INC. Increase (Decrease) in Accrued Interest Receivable, Net
POINT BIOPHARMA GLOBAL INC. reported Increase (Decrease) in Accrued Interest Receivable, Net of $1.40 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2023-09-30 was $2.09M, a 978.53% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2023-06-30 was -$972.82K.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2023-03-31 was $281.46K.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2022-09-30 was $193.68K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month |
|---|---|---|---|
| 2023-09-30 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.12M derived: sum of 2 quarters · filed 2023-11-13 | $1.40M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$972.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$691.36K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $281.46K 10-Q · filed 2023-05-15 | ||
| 2022-09-30 | $193.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $67.48K derived: sum of 2 quarters · filed 2023-11-13 | $67.48K 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$126.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$126.19K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 |